Bayer confirms sale of animal health unit to Elanco for $7.6bnThe rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the Share XBayer confirms sale of animal health unit to Elanco for $7.6bnhttps://pharmaphorum.com/news/bayer-confirms-sale-of-animal-health-unit-to-elanco-for-7-6bn/
Allergan says it will shed two drugs as AbbVie takeover loomsAllergan has confirmed that it will divest experimental inflammatory bowel disease therapy brazikumab and marketed drug Zenpep ahead Share XAllergan says it will shed two drugs as AbbVie takeover loomshttps://pharmaphorum.com/news/allergan-says-it-will-shed-two-drugs-as-abbvie-takeover-looms/
Embracing New Science for new growthThere is a quiet force in the biopharmaceutical industry that could have notable implications. The industry is clearly Share XEmbracing New Science for new growthhttps://pharmaphorum.com/r-d/views-analysis-r-d/new-science-for-new-growth/
Digital health M&A bounces back in Q2Mergers and acquisitions in digital health bounced back strongly in Q2 after almost grinding to a halt at Share XDigital health M&A bounces back in Q2https://pharmaphorum.com/news/digital-health-ma-bounces-back-in-q2/
Asia sees fast-paced digital health growthGalen Growth Asia CEO and founder Julien de Salaberry shares key trends and insights on the second largest Share XAsia sees fast-paced digital health growthhttps://pharmaphorum.com/views-analysis-digital/asia-sees-fast-paced-digital-health-growth/
Novartis trims again with $390m drugs sale to RecordatiNovartis has been streamlining its business since CEO Vas Narasimhan took over, and has continued that push with Share XNovartis trims again with $390m drugs sale to Recordatihttps://pharmaphorum.com/news/novartis-trims-again-with-390m-drugs-sale-to-recordati/
Bayer may merge animal health unit with Elanco; reportBayer has delayed a planned sale of its animal health unit to private equity interests in order to Share XBayer may merge animal health unit with Elanco; reporthttps://pharmaphorum.com/news/bayer-may-merge-animal-health-unit-with-elanco-report/
AbbVie ducks bolt-on trend and agrees Allergan mega-mergerUS drugmaker AbbVie has agreed to buy struggling Allergan in a $63 billion deal that continues a slew Share XAbbVie ducks bolt-on trend and agrees Allergan mega-mergerhttps://pharmaphorum.com/news/abbvie-ducks-bolt-on-trend-and-agrees-allergan-mega-merger/
UnitedHealth buys PatientsLikeMe after Trump interventionThe US health services giant UnitedHealth Group has bought PatientsLikeMe, which had been forced to find a buyer Share XUnitedHealth buys PatientsLikeMe after Trump interventionhttps://pharmaphorum.com/news/unitedhealth-buys-patientslikeme-after-trump-intervention/
